TransUnion Announces Pricing of Secondary Offering of 19,850,000 Shares of Common Stock and Purchase of 1,850,000 Shares of Common Stock

CHICAGO, IL--(Marketwired - February 15, 2017) - TransUnion (the "Company") (TRU) announced the pricing of the underwritten secondary offering by certain of its stockholders (the "Selling Stockholders") of 19,850,000 shares of common stock of the Company (the "common stock") pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission (the "Commission"). The shares will be offered from time to time for sale in one or more transactions on the New York Stock Exchange, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. The offering is expected to close on February 22, 2017, subject to customary closing conditions. In addition, certain of the Selling Stockholders have granted the underwriters a 30-day option to purchase up to 1,985,000 additional shares of common stock. The Selling Stockholders will receive all of the proceeds from this offering. No shares are being sold by the Company. The Company has agreed to purchase 1,850,000 shares of common stock from the underwriters in the offering.

Deutsche Bank Securities and BofA Merrill Lynch are acting as underwriters for the offering.

Upon the successful completion of the offering, the ownership of investment funds affiliated with each of Advent International Corporation ("Advent") and The Goldman Sachs Group, Inc. ("Goldman") in the Company will decline to below a threshold that triggers the immediate vesting of approximately 4.4 million employee options.

The offering will be made only by means of a prospectus supplement and accompanying prospectus. Copies of the preliminary prospectus supplement and accompanying prospectus related to the offering may be obtained from Deutsche Bank Securities, Attention: Prospectus Department, 60 Wall Street, New York, NY 10005 or by telephone at (800) 503-4611, or by email at prospectus.cpdg@db.com and BofA Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department, or by email at dg.prospectus_requests@baml.com.

The registration statement relating to these securities has been filed with the Commission and has become effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.